申请人:Elokdah Mahmoud Hassan
                            
                            
                                公开号:US20070037802A1
                            
                            
                                公开(公告)日:2007-02-15
                            
                            The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
                            本发明提供了一种式I化合物及其用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病的用途。